Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

NCT07155200 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer
Small Cell Lung Carcinoma
Small Cell Lung Cancer

Interventions

DRUG: Cirtuvivint
DRUG: Irinotecan

Sponsor

Washington University School of Medicine

Collaborators

[object Object]